外科随机对照试验的两个阿喀琉斯之踵:手术技能差异与平均性能报告
外科随机对照试验因难以设盲或实施假手术,且参与中心与术者技能存在差异,常仅报告术者与医院间的平均关联,导致并发症与不良结局仅以平均值呈现,可能不适用于个体术者或中心。本文以一项宫颈癌微创根治性子宫切除术的非劣效随机对照试验为例,说明手术技能变异未校正与平均结果报告不透明两个问题,并提出用稳健方法与统计方法克服这些缺陷。
要点
- 外科随机对照试验难以设盲或实施假手术,术者与中心技能差异是重要挑战。
- 多数试验仅报告术者与医院间的平均关联,并发症与不良结局仅以平均值呈现,不透明。
- 涉及两种竞争性复杂或新术式的试验可因技能变异及患者选择分期、术后辅助治疗等混杂因素而受巨大混杂影响。
核心结论
- 外科随机对照试验需关注手术技能变异未校正与平均结果报告不透明两个挑战,并可通过稳健方法与统计方法克服这些缺陷。
研究设计与样本
- 本文为观点类文章,以一项已发表的宫颈癌微创根治性子宫切除术非劣效随机对照试验为例进行说明。
主要发现
- 该非劣效随机对照试验报告,宫颈癌患者微创根治性子宫切除术相比开腹根治性子宫切除术,4.5年无病生存率较低(86% vs 96.5%),3年总生存率较低(93.8% vs 99%)。
- 涉及两种竞争性复杂或新术式的随机对照试验可因手术技能变异以及患者选择类别(如癌症分期)和术后辅助治疗等混杂因素未标准化而受巨大混杂影响。
- 多数试验仅报告术者与医院/中心间的平均关联,并发症与不良结局仅以平均值报告,这些平均值可能不适用于个体参与术者或中心。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出,此类随机对照试验因严格纳入与排除标准而存在固有的不可推广性,其结论可能不再适用于个体术者或中心的真实临床实践。
- 原文指出,涉及两种竞争性复杂或新术式的随机对照试验可因手术技能变异及患者选择分期、术后辅助治疗等混杂因素未标准化而受巨大混杂影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Randomized controlled trials of surgery are fundamentally different from randomized controlled trials of medications because it is difficult to blind or mask a surgical procedure or perform "sham" operations. An additional challenge is the variation in skills and surgical proficiency of participating centers and surgeons. Addressing heterogeneity in surgical proficiency remains of paramount importance, especially when randomized controlled trials involve a new or complex procedure such as minimally invasive radical surgery. In the presence of such heterogeneity, it is very cumbersome to evaluate objectively and monitor surgical skills so that most trials simply report associations that are averaged across surgeons and hospitals/centers. Such reporting is not transparent because the rates of complications and adverse outcomes are reported only as averages, and these averages may not apply to the individual participating surgeons or centers. These factors, coupled with the inherent nongeneralizability of findings from such randomized controlled trials, because of the strict inclusion and exclusion criteria for enrollment, may lead to conclusions that no longer apply to real life for individual surgeons or centers. Case in point is a recently published noninferiority randomized controlled trial that reported that minimally invasive radical hysterectomy was associated with lower rates of disease-free survival (86% vs 96.5% at 4.5 years) and overall survival (93.8% vs 99% at 3 years) than open abdominal radical hysterectomy in patients with cervical cancer. However, randomized controlled trials that involve 2 competing complex or new procedures may be affected by tremendous confounding because of variations in surgical proficiency and also nonstandardization for other confounding factors such as patient selection categories (ie, stage of cancer) and adjuvant postoperative therapies that may affect long-term survival. The purpose of this Viewpoint is not to provide an exhaustive review of the trial's shortcomings but to use it as an illustration to focus on 2 challenging areas that most randomized controlled trials of a new complex surgical procedure suffer from: (1) unadjusting or not correcting for surgical skill variability and (2) nontransparent reporting of averaged results. We provide suggestions to overcome these deficiencies through robust methods and statistical approaches.
引用
- Nezhat FR, Ananth CV, Vintzileos AM, et al. The two Achilles heels of surgical randomized controlled trials: differences in surgical skills and reporting of average performance. Am J Obstet Gynecol. 2019. PMID: 31121141. doi:10.1016/j.ajog.2019.05.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。